Connect with us

Technology

Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London

Published

3 weeks ago

on

Pioneering research by Dr. Naghavi’s team from American Heart Technologies and HeartLung.AI highlights AI’s transformative impact on early detection and prevention of fatal cardiovascular diseases.

LONDON, Aug. 30, 2024 /PRNewswire-PRWeb/ — American Heart Technologies and HeartLung.AI, leaders in the integration of artificial intelligence (AI) for the early detection and prevention of cardiovascular diseases, are thrilled to announce that seven of their scientific research studies have been accepted for presentation at the upcoming European Society of Cardiology (ESC) Annual Congress. The event, the world’s largest gathering of cardiovascular specialists, will be held in London from August 30 to September 2, 2024.

“I’m so proud of our team at American Heart Technologies and HeartLung.AI for this achievement. The recognition by ESC, speaks volumes for our team’s cutting-edge research and development to advance cardiovascular healthcare.” said Dr. Naghavi

The accepted presentations by American Heart Technologies and HeartLung.AI showcase cutting-edge research and innovations that have the potential to significantly impact cardiovascular healthcare. The studies, selected through a rigorous peer-review process, demonstrate the company’s ongoing commitment to advancing cardiovascular health through the power of AI.

https://esc365.escardio.org/ESC-Congress/abstract?text=HeartLung.ai&docType=All&days&page=1&vue=cards

Dr. Morteza Naghavi, the founder and president of American Heart Technologies and HeartLung.AI, expressed his pride in the team’s accomplishments: “I’m so proud of our team at American Heart Technologies and HeartLung.AI for this achievement. Not many academic research teams get 100% of their abstracts accepted let alone private companies. The recognition by ESC, which is the world’s largest assembly of cardiovascular specialists, speaks volumes for our team’s cutting-edge research and development to advance cardiovascular healthcare.”

The seven presentations shown below will cover a range of topics, all reflecting the innovative approach that American Heart Technologies and HeartLung.AI are known for. These studies include groundbreaking insights into AI-driven early detection techniques, predictive modeling for cardiovascular disease, and novel methodologies for patient care. “Our focus at American Heart Technologies and HeartLung.AI is on using AI for early detection and prevention of cardiovascular diseases,” Dr. Naghavi added. “These presentations are a testament to our dedication to improving patient outcomes and transforming cardiovascular healthcare on a global scale.”

For example, one of the AI tools developed at HeartLung enables doctors to flag patients who do not currently have atrial fibrillation (Afib) but are going to experience Afib within the new few months or new few years. This is not possible by current standards of care, but the AI development has made it possible to be used for patient care soon. This technology has recently been designated by the FDA as a Breakthrough AI and is on a fast track for approval.

“This AI research is truly groundbreaking and has the potential to reshape the public health to reduce preventable death” said Dr. David Yankelevitz, professor of radiology at Icahn School of Medicine at Mount Sinai, New York. “In collaborating with Dr. Naghavi’s team, our research center at Mount Sinai along with IELCAP (International Early Lung Cancer Action Program) is integrating these cutting-edge CT- based AI innovations into lung cancer screening for prevention of both heart disease and lung cancer, the number 1 and 2 causes of death in the United States.” Dr. Yankelevitz added.

About European Society of Cardiology (ESC)

The ESC Annual Congress is a prestigious event that draws thousands of professionals from around the world, providing a platform for the latest in cardiovascular research, technologies, and clinical practices. The acceptance of these presentations underscores the significant contributions that American Heart Technologies and HeartLung.AI are making to the field. Attendees of the ESC Congress are encouraged to attend these presentations to learn more about the latest advancements in AI applications for cardiovascular health, directly from the experts at American Heart Technologies and HeartLung.AI.

About IELCAP (International Early Lung and Cardiac Action Program)

IELCAP is an ongoing screening program that began accruing participants in 1994. It initially had two participating institutions, NYU and Cornell and now includes over 80 sites worldwide. The Principal Investigator for this program is Claudia Henschke PhD, MD, who is currently at Mount Sinai, which is the coordinating center for the program. I-ELCAP’s mission is to achieve early diagnosis, treatment, and ultimate cure of lung cancer through the rapid dissemination and advancement of research among a diversified, collaborative network.

About American Heart Technologies and HeartLung.AI

American Heart Technologies and HeartLung.AI are at the forefront of integrating artificial intelligence into cardiovascular healthcare. By focusing on the early detection and prevention of cardiovascular diseases, they are pioneering new approaches to improve patient outcomes and advance the field of cardiovascular medicine globally. For more information about American Heart Technologies and HeartLung.AI, please visit www.heartlung.ai or contact Michell Medellin at michel@heartlung.ai, 310-510-6004.

Media Contact

Michell Medellin, HeartLung.AI, 1 310-510-6004, michell@heartlung.ai, www.heartlung.ai

View original content to download multimedia:https://www.prweb.com/releases/seven-groundbreaking-ai-enabled-research-studies-to-be-presented-at-the-annual-congress-of-the-european-society-of-cardiology-2024-in-london-302234722.html

SOURCE HeartLung.AI

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Dana-Farber Cancer Institute Partners with Clinical.ly to Enhance Regulatory Operations with eReg Solutions

Published

32 mins ago

on

September 19, 2024

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — The Dana-Farber Cancer Institute, a world leader in cancer treatment and research, chose Clinical.ly’s (www.clinical.ly) Research Suite™ to streamline regulatory operations, marking a significant step toward more efficient and compliant clinical trial management. Dana-Farber joins a growing number of research organizations that leverage Clinical.ly’s innovative solutions to streamline clinical trial processes. Clinical.ly’s eReg platform offers a comprehensive, paperless solution that centralizes regulatory workflows, ensuring compliance and transparency across clinical trials.

“We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO.

This partnership continues Clinical.ly’s success in providing best-in-class enterprise tools for conducting clinical research. “We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO. “Our eReg platform and wider set of features in Clinical.ly Research Suite™ will empower that renowned organization, and we all look forward to supporting their teams.”

About Clinical.ly Research Suite™ 

Clinical.ly Research Suite™ is a comprehensive solution that eliminates traditional, paper-based processes. By automating and centralizing essential workflows in the Clinical.ly Research Suite™, organizations achieve huge efficiency improvements, greater trial oversight, document management, and regulatory compliance. The Clinical.ly Research Suite™ includes:

eReg: A best-in-class electronic regulatory bindereSource: An intuitive & feature-rich, paperless data capture solution that streamlines data collection from trial participantseConsent: A fully digital solution for capturing informed consent, improving participant engagement and site complianceClinicallySign: 21 CFR Part 11 compliant eSignature functionalityClinicallyPay: A secure and instantaneous participant stipend payment and reimbursement solution

About Dana-Farber Cancer Institute

Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with the best treatment available today while developing tomorrow’s cures through cutting-edge research. Based in Boston, Dana-Farber is a teaching affiliate of Harvard Medical School and ranks consistently as one of the top cancer hospitals in the world.

About Clinical.ly

Clinical.ly provides differentiated, cloud-native technology solutions to the clinical research industry, enabling research organizations to conduct studies with greater efficiency and ease. Clinical.ly is dedicated to developing technology that eliminates tedious manual labor, allowing clinical research professionals to focus on patient care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dana-farber-cancer-institute-partners-with-clinically-to-enhance-regulatory-operations-with-ereg-solutions-302253690.html

SOURCE Clinical.ly

Continue Reading

Technology

Fall Into Creativity with the Monport Laser Fall Sale

Published

32 mins ago

on

September 19, 2024

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — Experience laser innovation this Fall with Monport Laser, an industry frontrunner in laser engraving and cutting technology, with an exclusive Fall Sale offering incredible discounts and free accessories on a wide range of high-performance laser engraving machines. From September 19th to September 30th, customers can take advantage of this limited-time opportunity to elevate their laser engraving businesses with cutting-edge laser innovation at unbeatable prices.

Monport Laser has been dedicated to providing innovative and reliable laser machines that empower businesses and individuals to achieve their goals. With a focus on quality, precision, and customer satisfaction, Monport Laser has established itself as a trusted leader in the industry. Their commitment to excellence is evident in every laser they produce, ensuring exceptional performance, reliability, and value.

Embrace the Power of CO2 Laser Technology with Exclusive Offers

Monport Laser will offer two free accessories with selected CO2 laser machines during the Monport Fall sale. These versatile lasers are ideal for various applications, including engraving, cutting, and marking wood, acrylic, leather, and more. By taking advantage of this Fall sale, laser engraving businesses can enhance their productivity and expand their creative possibilities.

Experience Unmatched Value with Fiber Laser Discounts

Monport Laser offers substantial discounts of up to $4200 and 3 free accessories on selected models for those seeking the precision and speed of fiber laser technology. Fiber lasers are renowned for their ability to process metals with exceptional efficiency and accuracy, making them indispensable for metal fabrication, manufacturing, and jewelry production. Additionally, customers purchasing fiber lasers during the Fall sale will receive three free accessories, further sweetening the deal.

Elevate Your Desktop Laser Experience with a Free Water Chiller

Monport Laser is committed to providing comprehensive solutions for businesses of all sizes. As part of the Fall sale, customers who purchase the 40W Desktop laser will receive a Free Water Chiller Cw3000. This essential accessory ensures optimal cooling and performance, prolonging the lifespan of the laser and guaranteeing consistent results.

Discover Additional Savings on a Wide Range of Accessories

Monport Laser offers an additional 20% discount on selected accessories to complete your laser setup. From lenses and nozzles to rotary tables and smoke extraction systems, customers can find everything they need to maximize the potential of their laser machines.

Unleash Your Creativity and Productivity

Monport Laser’s Fall sale is the perfect opportunity to invest in laser technology that empowers your business or fuels your creative passions. With exceptional discounts and free accessories, you can acquire the ideal laser solution to meet your needs and budget.

Whether you’re an entrepreneur, artist, or manufacturer, Monport Laser’s advanced laser machines offer unparalleled precision, versatility, and reliability. Take advantage of this limited-time Fall sale and unlock your projects’ full potential for laser innovation.

About Monport Laser

Monport Laser is a global leader in designing, manufacturing, and distributing high-quality laser machines and accessories. With a commitment to innovation and customer satisfaction, Monport Laser provides cutting-edge solutions for various industries, including manufacturing, engraving, marking, and more.

For more information, visit monportlaser.com and follow them on social media for the latest updates.

Website: https://www.monportlaser.com/

 

 

 

View original content:https://www.prnewswire.com/news-releases/fall-into-creativity-with-the-monport-laser-fall-sale-302253699.html

SOURCE Monport Laser

Continue Reading

Technology

MEDIA ADVISORY – Minister Wilkinson to Make a Critical Minerals Infrastructure Announcement

Published

32 mins ago

on

September 19, 2024

By

VANCOUVER, BC, Sept. 19, 2024 /CNW/ – The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, and Ranj Pillai, the Premier of Yukon, will make a funding announcement in support of critical minerals infrastructure projects. A media availability will follow.

Date: September 20, 2024

Time: 10:30 a.m. PT

All accredited media are asked to pre-register by emailing media@nrcan-rncan.gc.ca. A dial-in line is available for media and will be provided upon registration.

Follow us on LinkedIn

SOURCE Natural Resources Canada

Continue Reading

Trending